AMBS is down 55.5% since the high of .1935 on July 29th.

New Post Public Reply Private Reply Replies (2) Message Board
biotechexpert
AMBS is down 55.5% since the high of .1935 on July 29th. That is a massive and rapid .1075 cents decline in less than 2 months. If that's GC's definition of creating shareholder value than I want the BOD to find another CEO pronto. You can easily verify this yourself. Unless some major event or two happens that completely turns this stock around, I would not expect any uplisting this year unless GC again does the opposite of what he has said he wouldn't do and engages in a massive R/S to uplist.

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Innovative Green Technologies from Shanghai Electric Transform Energy Landscape

Updated Category News Views 295

Innovative Green Technologies from Shanghai Electric Transform Energy Landscape Shanghai Electric has remarkable aspirations for a sustainable and cleaner future. At a recent summit, the company proudly showcased its pioneering technologies geared towards green energy, including advancements in green hydrogen, sustainable formaldehyde production, photovoltaics,...

Continue Reading
Northview Residential REIT Declares August Cash Distribution

Updated Category News Views 163

Northview Residential REIT Announces Cash Distribution CALGARY, Alberta — Today, Northview Residential REIT, often recognized for its focus on quality real estate investments, made an important announcement regarding its August 2025 cash distribution amounts. This announcement showcases the REIT’s ongoing commitment to providing value to its investors. Details of the...

Continue Reading
Virpax Pharmaceuticals Sees Major Surge After Army Study Results

Updated Category News Views 203

Virpax Pharmaceuticals Experiences Remarkable Growth Virpax Pharmaceuticals, Inc. recently made headlines as their stock witnessed an impressive surge. This excitement primarily stems from the successful conclusion of a preclinical study that the U.S. Army's Institute of Surgical Research conducted. The study was part of a larger effort aimed at enhancing pain management...

Continue Reading
Boomi Celebrates Recognition as Top Workplace for Innovators

Updated Category News Views 39

Boomi recognized for building an innovative workplace Boomi™, the intelligent integration and automation leader, was named to Fast Company’s annual Best Workplaces for Innovators list. The honor underscores Boomi’s focus on creating a place where new ideas move freely, teams experiment, and that open exchange shows up in how customers are supported every day. How...

Continue Reading
Faruqi & Faruqi, LLP Investigates Marex Group Claims for Investors

Updated Category News Views 186

Faruqi & Faruqi, LLP Launches Investigation for Marex Group Investors Investors who have faced difficulties due to their investments in Marex Group plc are encouraged to reach out to Faruqi & Faruqi, LLP. The leading national securities law firm specializing in protecting investors' rights has begun a new investigation aimed at determining the merits of claims against the...

Continue Reading